References
- Rush RW, Keirse MJ, Howat P, et al. Contribution of preterm delivery to perinatal mortality. Br J Med 1976: 2(6042): 965–8
- Johnson JW. Obstetrical aspects of preterm delivery. Clin Obstet Gynecol 1980: 23(1): 15–16
- Hemminki E, Starfield B. Prevention and treatment of premature labour by drugs: review of controlled trials. Br J Obstet Gynaecol 1978: 85(6): 411–7
- Zlatnik FJ. The applicability of labor inhibition to the problem of prematurity. Am J Obstet Gynecol 1972: 113(Jul 1): 704–6
- Valenzuela G, Hayashi R. Are beta-mimetic drugs the solution for prematurity? Presented before Society of Perinatal Obstetricians. San Antonio: Jan 1981
- Herron MA, Katz M, Creasy RK. Evaluation of a preterm birth prevention program: preliminary report. Obstet Gynecol 1982: 59(4): 452–6
- Kaltreider DF, Kohl S. Epidemiology of preterm delivery. Clin Obstet Gynecol 1980: 23(1): 17–31
- Berkowitz GS. An epidemiologic study of preterm delivery. Am J Epidemiol 1981: 113(1): 81–92
- Papiernik-Berkhauer E. Coefficient de risque d'accouchement premature. Presse Med 1969: 77(21): 793–4
- Fedrick J. Antenatal identification of women at high risk of spontaneous preterm birth. Br J Obstet Gynaecol 1976: 83(5): 351–4
- Creasy RK. Gummer BA, Liggins GC. A system for predicting spontaneous preterm birth. Obstet Gynecol 1980: 55(6): 692–5
- World Health Organization. Recommended definitions, terminology, and formulae for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal death. Acta Obstet Gynecol Scand 1977: 56(3): 247–53
- Merkatz IR, Peter JB, Barden TP. Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. II. Evidence of efficacy. Obstet Gynecol 1980: 56(1): 7–12
- Spellacy WN, Cruz AC, Birk SA, et al. Treatment of premature labor with ritodrine: a randomized controlled study. Obstet Gynecol 1979: 54(2): 220–3
- Spisso KR, Harbert GM Jr, Thiagarajah S. The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery. Am J Obstet Gynecol 1982: 142(7): 840–5
- Wesselius-de Casparis A, Thiery M, Yo le Sian A, et al. Results of a double-blind. multicentre study with ritodrine in premature labour. Br J Med 1971: 3(767): 1447
- Fuchs F, Fuchs AR, Poblete VF Jr, et al. Effect of alcohol on threatened premature labor. Am J Obstet Gynecol 1967: 99(5): 627–37
- Phillpsen T, Eriksen PS, Lynggard F. Pulmonary edema following ritodrine-saline infusion in premature labor. Obstet Gynecol 1981: 58: (3)304–8
- Barden T, Peter JB, Merkatz IR. Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. 1. Pharmacology, clinical history, administration, side effects, and safety. Obstet Gynecol 1980: 56(1): 1–6
- Ying YK, Tejani NA. Angina pectoris as a complication of ritodrine hydrochloride therapy in premature labor. Obstet Gynecol 1982: 60(3): 385–8
- Tinga DJ, Aarronoudse JG. Post-partum pulmonary oedema associated with preventive therapy for premature labor. Lancet 1979: 1(8124): 1026
- Katz M, Robertson PA, Creasy RK. Cardiovascular complications associated with terbutaline treatment for preterm labor. Am J Obstet Gynecol 1981: 139(5): 605–8
- Elliott HR, Abdulla U, Hayes PJ. Pulmonaiy oedema associated with ritodrine infusion and betamethasone administration in premature labor. Br Med J 1978: 2(6140): 799–800
- Creasy RK, Golbus MS, Laros RK Jr, et al. Oral ritodrine maintenance in the treatment of preterm labor. Am J Obstet Gynecol 1980: 137(2): 212–9
- Brown SM, Tejani NA. Terbutaline sulfate in the prevention of recurrence of premature labor. Obstet Gynecol 1981: 57(1): 22–5
- Lipshitz J. The uterine and cardiovascular effects of oral fenoterol hydrobromide. Br J Obstet Gynaecol 1977: 84(10): 737–9